Navigation Links
China Kanghui Holdings Announces Participation in Upcoming Investor Conferences
Date:10/27/2011

CHANGZHOU, China, Oct. 27, 2011 /PRNewswire-Asia/ -- China Kanghui Holdings (NYSE: KH) ("Kanghui" or the "Company"), a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced its participation in the following investor events:

  • Bank of America Merrill Lynch New China Conference to be held on October 31 - November 4, 2011 at the JW Marriot Hotel in Beijing, China.  Management is scheduled to meet with institutional investors on November 2, 2011.
  • CLSA AsiaUSA Forum to be held on November 7 - 9, 2011 at the Palace Hotel in San Francisco.  Management is scheduled to present on November 7, 2011 at 11.30 a.m. and meet with institutional investors throughout the day.
  • Cowen China Opportunity Inaugural Conference to be held on November 15 - 16, 2011 at the St. Regis Hotel in Beijing, China.  Management is scheduled to present on November 15, 2011 at 9 a.m. and meet with institutional investors throughout the day.
  • Lazard Capital Markets 8th Annual Healthcare Conference to be held on November 15 - 16, 2011 at the Pierre Hotel in New York City.  Management is scheduled to present on November 15, 2011 at 8.30 a.m. and meet with institutional investors throughout the day.
  • Morgan Stanley Asia Pacific Summit to be held on November 16 - 17, 2011 at Mandarin Oriental Hotel in Singapore.  Management is scheduled to meet with institutional investors throughout the 2 days.
  • Piper Jaffray 23rd Annual Healthcare Conference to be held on November 29 - 30, 2011 at the New York Palace Hotel in New York City. Management is scheduled to present on November 30, 2011 at 3 p.m. and meet with institutional investors throughout the day.
  • Oppenheimer & Co. 22nd Annual Healthcare Conference to be held on December 13 - 14, 2011 at the Waldorf Astoria Hotel in New York City.  Management is scheduled to present on December 13, 2011 at 8.50 a.m. and meet with institutional investors throughout the day.

About China Kanghui Holdings

Founded in 1997, Kanghui is a leading domestic developer, manufacturer and marketer of orthopedic implants in China. The Company offers a wide array of proprietary orthopedic implant products in trauma and spine. It has an extensive network of distributors for its products in China. In addition, Kanghui's products are distributed in 28 countries. Kanghui has strong research and development capabilities, focused on developing new proprietary products, including new product lines, extensions of existing product lines and enhancements of existing products. For more information, please visit www.kanghui.com.

Contact:
China Kanghui Holdings Investor Relations Department  
+1-888-321-2558

Asia Bridge Capital Limited
Carene Toh
+86-186 1835 6339
carene.toh@asiabridgegroup.com


'/>"/>
SOURCE China Kanghui Holdings
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
2. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
3. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
4. HUYA Bioscience Intl Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
5. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
6. RHEI Pharmaceuticals Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China
7. Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition
8. China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit
9. China Animal Welfare Law Under Review While 36,000 Dogs Culled
10. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
11. Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... 2017   ZirMed Inc ., a recognized leader in ... it has been ranked #1 by its users for the ... 2017 User Survey. ZirMed was recognized as the top-ranked end-to-end ... medical centers over 200 beds and holds one of the ... survey history. ...
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform for ... the first annual edition of its Global CSR Risk and Performance Index. ... by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points ... ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
(Date:10/13/2017)... ... 2017 , ... “The Journey: From the Mountains to the Mission Field”: the ... in the Philippines. “The Journey: From the Mountains to the Mission Field” is the ... She has taught all ages and currently teaches a class of ladies at her ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. ... recently contributed a medical article to the newly revamped Cosmetic Town journal ... spotlights the hair transplant procedure known as Follicular Unit Extraction (FUE). ...
(Date:10/12/2017)... ... 12, 2017 , ... Health Literacy Innovations (HLI), creator of ... and the Cancer Patient Education Network (CPEN), an independent professional organization that shares ... strategic alliance. , As CPEN’s strategic partner, HLI will help support CPEN ...
Breaking Medicine News(10 mins):